Robert Law

Robert is an industrious molecular and cell biology expert with more than a decade of experience conducting research in the areas of biopharmaceutical engineering, genome editing, and cancer cell biology. He has utilized his proficiency in these areas to execute product development strategies within the gene editing space in addition to spearheading research efforts to delineate complex cell signaling pathways for the identification of diagnostic and therapeutic targets to combat cancer. His work has resulted in several publications in Science Advances, Science Signaling, Journal of Cell Biology, and Cancer Research.

As an innovative and dynamic scientist, Robert is committed to solving challenging problems centered around cancer diagnostics and prevention. At AOA Dx, he is using his skills and expertise to develop AOA’s ovarian cancer diagnostic test in conjunction with expanding the GlycoLocate™ platform to enable the detection of additional cancer targets.